Pasar al contenido principal

APROXIMACIONES BASADAS EN LA DIANA Y FENOTIPICAS PARA EL DESCUBRIMIENTO DE NUEVOS FARMACOS CONTRA LAS TRIPANOSOMIASIS AFRICANA Y AMERICANA

SAF2015-66690-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Conjugates of 2,4-Dihydroxybenzoate and Salicylhydroxamate and Lipocations Display Potent Antiparasite Effects by Efficiently Targeting the Trypanosoma brucei and Trypanosoma congolense Mitochondrion

  • Fueyo-González, Francisco
  • de Koning, Harry P.
  • Ebiloma, Godwin U.
  • Izquierdo García, Carolina
  • Bruggeman, V.
  • Sánchez Villamañán, J. M.
  • Donachie, Anne
  • Balogun, Emmanuel O.
  • Inaoka, D. K.
  • Shiba, T.
  • Harada, S.
  • Dardonville, Christophe
We investigated a chemical strategy to boost the trypanocidal activity of 2,4-dihydroxybenzoic acid (2,4-DHBA)- and salicylhydroxamic acid (SHAM)-based trypanocides with triphenylphosphonium and quinolinium lipophilic cations (LC). Three series of LC conjugates were synthesized that were active in the submicromolar (5a-d and 10d-f) to low nanomolar (6a-f) range against wild-type and multidrug resistant strains of African trypanosomes (Trypanosoma brucei brucei and T. congolense). This represented an improvement in trypanocidal potency of at least 200-fold, and up to >10 000-fold, compared with that of non-LC-coupled parent compounds 2,4-DHBA and SHAM. Selectivity over human cells was >500 and reached >23 000 for 6e. Mechanistic studies showed that 6e did not inhibit the cell cycle but affected parasite respiration in a dose-dependent manner. Inhibition of trypanosome alternative oxidase and the mitochondrial membrane potential was also studied for selected compounds. We conclude that effective mitochondrial targeting greatly potentiated the activity of these series of compounds., The logistical collaboration of Drs. Jagerovic, Goya, and Herranz is gratefully acknowledged. This work was funded by the Spanish Ministerio de Economia y Competitividad (SAF2015-66690-R). G.U.E. was supported by a TET-fund studentship from the government of Nigeria and by a Mac Robertson Travel Scholarship from the College of Medical, Veterinary and Life Sciences of the University of Glasgow, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Substituent effects on the basicity (p: K a) of aryl guanidines and 2-(arylimino)imidazolidines: Correlations of pH-metric and UV-metric values with predictions from gas-phase ab initio bond lengths

  • Dardonville, Christophe
  • Caine, B. A.
  • Navarro de la Fuente, Marta
  • Martín Herranz, Guillermo
  • Corrales Mariblanca, Beatriz
  • Popelier, Paul L. A.
The dissociation constants of two related series of 2-(arylimino)imidazolidine and aryl guanidine α-adrenoceptor antagonists (35 compounds in total) were measured by potentiometric titrations and by UV-spectrophotometry using the 96-well microtitre plate method. The experimental values obtained using both methods were quite consistent and showed a very good agreement with the pK values calculated using the AIBLHiCoS methodology, which uses only a single bond length obtained using ab initio calculations at a low level of theory. The prediction power of the imidazolidine and guanidine set of compounds was very good with deviations typically <0.30 and <0.24 pK units, and a mean absolute error (MAE) of 0.23 and 0.29, respectively. The study of the quantitative effect of diverse substituents on the basicity of aryl guanidine and 2-(arylimino)imidazolidine derivatives is useful for medicinal chemists working with biologically relevant guanidine-containing molecules., This work was supported by the Spanish Ministerio de Economia y Competitividad (Grant SAF2015-66690-R). B. A. Caine thanks BBSRC and Syngenta Ltd for PhD funding. P. L. A. P. acknowledges the EPSRC for funding through the award of an Established Career Fellowship (grant EP/K005472). We acknowledge the assistance of G. Romero and F. Peréz Gordillo (Instrumental Analysis Department at IQM) with the potentiometric pKa measurements. We thank Chanse`le Jourdan for her assistance with the UV-metric pKa measurements. Dr Rozas is gratefully acknowledged for the gift of the pyridino derivatives 16–22 and the Boc-protected precursors of compounds 1–10 and 23–27., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional and structural analysis of AT-specific minor groove binders that disrupt DNA-protein interactions and cause disintegration of the Trypanosoma brucei kinetoplast

  • Millan, C. R.
  • Acosta-Reyes, F. J..
  • Lagartera, Laura
  • Ebiloma, Godwin U.
  • Lemgruber, L.
  • Nué Martínez, J. Jonathan
  • Saperas, Nuria
  • Dardonville, Christophe
  • de Koning, Harry P.
  • Campos, J. Lourdes
Trypanosoma brucei, the causative agent of sleeping sickness (Human African Trypanosomiasis, HAT), contains a kinetoplast with the mitochondrial DNA (kDNA), comprising of >70% AT base pairs. This has prompted studies of drugs interacting with AT-rich DNA, such as the N-phenylbenzamide bis(2-aminoimidazoline) derivatives 1 [4-((4,5-dihydro-1H-imidazol-2-yl)amino)-N-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)phenyl)benzamide dihydrochloride] and 2 [N-(3-chloro-4-((4,5-dihydro-1H-imidazol-2-yl)amino)phenyl)-4-((4,5-dihydro-1H-imidazol-2-yl)amino)benzamide] as potential drugs for HAT. Both compounds show in vitro effects against T. brucei and in vivo curative activity in a mouse model of HAT. The main objective was to identify their cellular target inside the parasite. We were able to demonstrate that the compounds have a clear effect on the S-phase of T. brucei cell cycle by inflicting specific damage on the kinetoplast. Surface plasmon resonance (SPR)-biosensor experiments show that the drug can displace HMG box-containing proteins essential for kDNA function from their kDNA binding sites. The crystal structure of the complex of the oligonucleotide d[AAATTT]2 with compound 1 solved at 1.25 Å (PDB-ID: 5LIT) shows that the drug covers the minor groove of DNA, displaces bound water and interacts with neighbouring DNA molecules as a cross-linking agent. We conclude that 1 and 2 are powerful trypanocides that act directly on the kinetoplast, a structure unique to the order Kinetoplastida., Spanish Ministerio de Economia y Competitividad [SAF2015-66690-R to C.D.]; Spanish Ministerio de Ciencia e Innovaci ´on [BFU2009-10380 to J.L.C.]; Generalitat de Catalunya [project SRG2009-1208 to J.L.C.]; Spanish Ministerio de Educaci´on, Cultura y Deporte [FPU12/04824, EST14/00449 to C.R.M.]; CONACYT [312212 to C.R.M.]; Short Term Scientific Mission COST Action CM1307 [COST-STSM-CM1307–35281 to C.R.M.]; PhD studentship from the Tertiary Education Trust Fund of the Federal Government of Nigerian [TETFUND-2011/2012 to G.U.E.]; Wellcome Centre for Molecular Parasitology is supported by core funding from theWellcome Trust [085349, L.L.]. Funding for open access charge: SpanishMinisterio de Economia y Competitividad [Grant SAF2015-66690-R]. Conflict of interest statement. None declared., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification, occurrence and activity of quinazoline alkaloids in Peganum harmala

  • Herraiz Tomico, Tomás
  • Guillén Fuerte, Hugo
  • Arán, Vicente J.
  • Salgado, Antonio
Peganum harmala L. is a medicinal plant from the Mediterranean region and Asia currently used for recreative psychoactive purposes (Ayahuasca analogue), and increasingly involved in toxic cases. Its psychopharmacological and toxicological properties are attributed to quinazoline and β-carboline alkaloids. In this work three major quinazoline alkaloids were isolated from P. harmala extracts and characterized as peganine (vasicine), deoxypeganine (deoxyvasicine) and a novel compound identified by HPLC-DAD-MS and NMR as peganine β-D-glucopyranosyl-(1 → 6)-β-D-glucopyranoside (peganine glycoside). Peganine appeared in flowers and leaves in high levels; high amounts of deoxypeganine and peganine were found in immature and green fruits whereas peganine and peganine glycoside accumulated in high amount in dry seeds reaching up to 1 and 3.9% (w/w), respectively. Roots and stems contained low amount of quinazolines. Seeds extracts containing both quinazoline and β-carboline alkaloids potently inhibited human monoamine oxidase (MAO)-A. However, quinazoline alkaloids did not contribute to MAO inhibition that was due to β-carbolines, suggesting that MAO-related psychoactive or toxic actions do not arise from quinazolines. Quinazoline alkaloids were poor radical scavengers in the ABTS assay whereas seed extracts had good activity. Quinazoline alkaloids are known to exert bronchodilator and abortifacient actions, and could contribute to such effects reported in P. harmala., The authors are grateful to MINECO (SAF2015-66690-R and SAF2015-68580-C2-2-R), and CSIC (Spain) (project 200470E658) for supporting this work., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prediction of Aqueous p K a Values for Guanidine-Containing Compounds Using Ab Initio Gas-Phase Equilibrium Bond Lengths

  • Caine, B. A.
  • Dardonville, Christophe
  • Popelier, Paul L. A.
In this work, we demonstrate the existence of linear relationships between gas-phase equilibrium bond lengths of the guanidine skeleton of 2-(arylamino)imidazolines and their aqueous pK value. For a training set of 22 compounds, in the most stable conformation of their lowest energy tautomeric form, three bonds were found to exhibit r and q values >0.95 and root-mean-squared-error of estimation values ≤0.25 when regressed individually against pK. The equations describing these one-bond-length linear relationships, in addition to a multiple linear regression model using all three bond lengths, were then used to predict the experimental pK values of an external test set of further 27 derivatives. The optimal protocol we derive here shows an overall mean absolute error (MAE) of 0.20 and standard deviation of errors of 0.18 for the test set. Predictions for a second test set of diphenyl-based bis(2-iminoimidazolidines) yielded an MAE of 0.27 and a standard deviation of 0.10. The predictive power of the optimal model is further demonstrated by its ability to correct erroneously reported experimental values. Finally, a previously established guanidine model is recalibrated at a new level of theory, and predictions are made for novel phenylguanidine derivatives, showing an MAE of just 0.29. The protocols established and tested here pass both of Roy's modern and stringent MAE-based criteria for a >good> quantitative structure-activity relationship/quantitative structure-property relationship model predictivity. Notably, the ab initio bond length high correlation subset protocol developed in this work demonstrates lower MAE values than the Marvin program by ChemAxon for all test sets., P.L.A.P. thanks the EPSRC for Fellowship funding (EP/ K005472), and B.A.C. thanks the BBSRC “iCASE” award BB/ L016788/1 and Syngenta Ltd for funding her PhD studentship. C.D. thanks the Spanish Ministerio de Economia y Competitividad (grant SAF2015-66690-R)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense

  • Ebiloma, Godwin U.
  • Díaz, Teresa
  • Balogun, Emmanuel O.
  • Abad, Lucía
  • Donachie, Anne
  • Kaiser, Marcel
  • Herraiz Tomico, Tomás
  • Inaoka, Daniel K.
  • Shiba, Tomoo
  • Harada, Shigeharu
  • Kita, Kiyoshi
  • Koning, Harry P. de
  • Dardonville, Christophe
African trypanosomiasis is a neglected parasitic disease that is still of great public health relevance, and a severe impediment to agriculture in endemic areas. The pathogens possess certain unique metabolic features that can be exploited for the development of new drugs. Notably, they rely on an essential, mitochondrially-localized enzyme, Trypanosome Alternative Oxidase (TAO) for their energy metabolism, which is absent in the mammalian hosts and therefore an attractive target for the design of safe drugs. In this study, we cloned, expressed and purified the physiologically relevant form of TAO, which lacks the N-terminal 25 amino acid mitochondrial targeting sequence (ΔMTS-TAO). A new class of 32 cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde inhibitors was designed and synthesized, enabling the first structure-activity relationship studies on ΔMTS-TAO. Remarkably, we obtained compounds with enzyme inhibition values (IC) as low as 2 nM, which were efficacious against wild type and multidrug-resistant strains of T. brucei and T. congolense. The inhibitors 13, 15, 16, 19, and 30, designed with a mitochondrion-targeting lipophilic cation tail, displayed trypanocidal potencies comparable to the reference drugs pentamidine and diminazene, and showed no cross-resistance with the critical diamidine and melaminophenyl arsenical classes of trypanocides. The cationic inhibitors 15, 16, 19, 20, and 30 were also much more selective (900 - 344,000) over human cells than the non-targeted neutral derivatives (selectivity >8-fold). A preliminary in vivo study showed that modest doses of 15 and 16 reduced parasitaemia of mice infected with T. b. rhodesiense (STIB900). These compounds represent a promising new class of potent and selective hits against African trypanosomes., This work was funded by the Spanish Ministerio de Economia y Competitividad (SAF2015-66690-R). This investigation also received financial support (ID No. B40103 to EOB) from TDR, the Special Programme for Research and Training in Tropical Diseases (co-sponsored by UNICEF, UNDP, the World Bank and WHO). G. U. Ebiloma was supported by a TET-Fund studentship from the government of Nigeria and by a Mac Robertson Travel Scholarship from the College of Medical, Veterinary and Life Sciences of the University of Glasgow., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants

  • Herraiz Tomico, Tomás
  • Flores, Andrea
  • Fernández, Lidia
Monoamine oxidase (MAO) enzymes catalyze the oxidative deamination of biogenic amines and neurotransmitters and produce ammonia, aldehydes, and hydrogen peroxide which is involved in oxidative processes. Inhibitors of MAO-A and -B isozymes are useful as antidepressants and neuroprotectants. The assays of MAO usually measure amine oxidation products or hydrogen peroxide by spectrophotometric techniques. Those assays are often compromised by interfering compounds resulting in poor results. This research describes a new method that combines in the same assay the oxidative deamination of kynuramine to 4-hydroxyquinoline analyzed by HPLC-DAD with the oxidation of tetramethylbenzidine (TMB) (or Amplex Rex) by horseradish peroxidase (HRP) in presence of hydrogen peroxide. The new method was applied to study the inhibition of human MAO-A and -B by bioactive compounds including β-carboline alkaloids and flavonoids occurring in foods and plants. As determined by HPLC-DAD, β-carbolines, methylene blue, kaempferol and clorgyline inhibited MAO-A and methylene blue, 5-nitroindazole, norharman and deprenyl inhibited MAO-B, and all of them inhibited the oxidation of TMB in the same extent. The flavonoids catechin and cyanidin were not inhibitors of MAO by HPLC-DAD but highly inhibited the oxidation of TMB (or Amplex Red) by peroxidase whereas quercetin and resveratrol were moderate inhibitors of MAO-A by HPLC-DAD, but inhibited the peroxidase assay in a higher level. For some phenolic compounds, using the peroxidase-coupled assay to measure MAO activity led to mistaken results. The new method permits to discern between true inhibitors of MAO from those that are antioxidants and which interfere with peroxidase assays but do not inhibit MAO. For true inhibitors of MAO, inhibition as determined by HPLC-DAD correlated well with inhibition of the oxidation of TMB and this approach can be used to assess the in vitro antioxidant activity (less hydrogen peroxide production) resulting from MAO inhibition., The authors thank MINECO-FEDER for the projects SAF2015-66690-R and SAF2015-68580-C2-2-R and CSIC (project 200470E658) for supporting this work., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Monoamine oxidase-A inhibition and associated antioxidant activity in plant extracts with potential antidepressant actions

  • Herraiz Tomico, Tomás
  • Guillén Fuerte, Hugo
Monoamine oxidase (MAO) catalyzes the oxidative deamination of amines and neurotransmitters and is involved in mood disorders, depression, oxidative stress, and adverse pharmacological reactions. This work studies the inhibition of human MAO-A by Hypericum perforatum, Peganum harmala, and Lepidium meyenii, which are reported to improve and affect mood and mental conditions. Subsequently, the antioxidant activity associated with the inhibition of MAO is determined in plant extracts for the first time. H. perforatum inhibited human MAO-A, and extracts from flowers gave the highest inhibition (IC of 63.6 μg/mL). Plant extracts were analyzed by HPLC-DAD-MS and contained pseudohypericin, hypericin, hyperforin, adhyperforin, hyperfirin, and flavonoids. Hyperforin did not inhibit human MAO-A and hypericin was a poor inhibitor of this isoenzyme. Quercetin and flavonoids significantly contributed to MAO-A inhibition. P. harmala seed extracts highly inhibited MAO-A (IC of 49.9 μg/L), being a thousand times more potent than H. perforatum extracts owing to its content of β-carboline alkaloids (harmaline and harmine). L. meyenii root (maca) extracts did not inhibit MAO-A. These plants may exert protective actions related to antioxidant effects. Results in this work show that P. harmala and H. perforatum extracts exhibit antioxidant activity associated with the inhibition of MAO (i.e., lower production of HO)., The authors are grateful to MINECO-FEDER (SAF2015-66690-R and SAF2015-68580-C2-R) and CSIC (Spain) (Project 200470E658) for supporting this work., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nitrosative deamination of 2′-deoxyguanosine and DNA by nitrite, and antinitrosating activity of β-carboline alkaloids and antioxidants

  • Herraiz Tomico, Tomás
  • Galisteo, Juan
Endogenous and dietary nitrite produces reactive nitrogen species (RNS) that react with DNA causing mutations. The nitrosation of 2′-deoxyguanosine (dGuo) and DNA with nitrite was studied under different conditions, and the reaction and degradation products identified and analysed by HPLC-DAD-MS. Nitrosative deamination of dGuo produced xanthine along with 2′-deoxyxanthosine whereas DNA afforded xanthine. Formation of xanthine increased with nitrite concentration and in low pH such as that of stomach. Xanthine was measured as a marker of nitrosation of dGuo and DNA, and it was subsequently used to study the antinitrosating activity of β-carboline alkaloids, and selected antioxidants. Food-occurring tetrahydro-β-carbolines (THβCs) decreased nitrosative deamination of dGuo and DNA under conditions simulating the stomach. Antinitrosating activity was also evidenced for flavonoids (catechin, quercetin) and indole (melatonin) antioxidants. Among THβCs the most active antinitrosating compounds were 1,2,3,4-tetrahydro-β-carboline-3-carboxylic acids (THβC-3-COOHs) that reacted with nitrite to give N-nitroso derivatives as main products along with 3,4-dihydro-β-carboline-3-carboxylic acids and aromatic β-carbolines (norharman and harman). Antinitrosating activity of THβCs correlated well with the formation of N-nitroso-THβC-3-COOHs. These N-nitroso derivatives were stable at pH 7 but degraded in acid conditions affording nitrosating species., The authors thank MINECO-FEDER (projects SAF2015-66690-R and SAF2015-68580-C2-2-R) and CSIC (project 200470E658) for supporting this work., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antichagasic, Leishmanicidal, and Trichomonacidal Activity of 2-Benzyl-5-nitroindazole-Derived Amines

  • Fonseca-Berzal, Cristina
  • Ibáñez-Escribano, Alexandra
  • Vela, Nerea
  • Cumella, José
  • Nogal-Ruiz, Juan José
  • Escario, José Antonio
  • da Silva, P. B.
  • Soeiro, M. N. C.
  • Sifontes-Rodríguez, S
  • Meneses-Marcel, Alfredo
  • Gómez-Barrio, Alicia
  • Arán, Vicente J.
Three different series of new 5-nitroindazole derivatives—1-(ω-aminoalkyl)-2-benzylindazolin-3-ones (series A; ten compounds), 3-(ω-aminoalkoxy)-2-benzylindazoles (series B; four compounds) and 3-alkylamino-2-benzylindazoles (series C; five compounds)—have been synthesized and evaluated against the protozoan parasites Trypanosoma cruzi, Leishmania amazonensis, and Trichomonas vaginalis: etiological agents of Chagas disease, cutaneous leishmaniasis, and trichomoniasis, respectively. Many indazoles of series A, B, and C were efficient against T. cruzi. Some compounds in series A, after successfully passing the preliminary screening for epimastigotes, exhibited activity values against amastigotes of several T. cruzi strains that were better than or similar to those shown by the reference drug benznidazole and displayed low nonspecific toxicity against mammalian cells. On the other hand, preliminary studies against promastigotes of L. amazonensis showed high leishmanicidal activity for some derivatives of series A and C. With regard to activity against T. vaginalis, some indazoles of series B and C were rather efficient against trophozoites of a metronidazole-sensitive isolate and showed low nonspecific toxicities toward Vero cell cultures. Additionally, some of these compounds displayed similar activity against metronidazole-sensitive and resistant isolates, showing the absence of cross-resistance between these derivatives and the reference drug., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINEICO; ref. SAF2015-66690-R), by the 911120 UCM-CEI Moncloa research group (E-Health Cluster), by the National Council for Scientific and Technological Development of Brazil (CNPq; ref. 301372/2015-2) and by the Fundaçao Carlos Chagas Filho de Amparo / Pesquisa do Estado do Rio de Janeiro (FAPERJ; ref. E02/2017). M.N.C.S. is a research fellow of CNPq and CNE. The authors thank the Program for Technological Development in Tools for Health (PDTIS-FIOCRUZ) for use of their facilities., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

N-methyltetrahydropyridines and pyridinium cations as toxins and comparison with naturally-occurring alkaloids

  • Herraiz Tomico, Tomás
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium cation (MPP) are selective dopaminergic neurotoxins producing Parkinsonism. MPTP is activated by monoamine oxidase-B (MAO-B) to MPP that inhibits mitochondrial function. Molecules resembling MPTP which afford pyridinium cations are also neurotoxins. The herbicide paraquat (a bipyridinium dication) and the naturally-occurring β-carboline and isoquinoline alkaloids are structural analogues of MPTP/MPP. Paraquat generates reactive oxygen species (ROS) producing neurotoxicity by a mechanism that differs from MPTP/MPP. Human exposure to PQ is increasingly associated with neurodegeneration. Tetrahydro-β-carbolines (THβCs), β-carbolines (βCs) and tetrahydroisoquinolines (TIQ) are bioactive compounds occurring in foods and the human body. They are not MPTP-like toxins and do not appear to induce neurotoxicity at normal levels of exposure. Among TIQs, endogenous dopamine-derived TIQs (i.e. salsolinol) and 1-benzyl-TIQ are toxic through ROS generation. In contrast, β-carbolinium (βCs) and isoquinolinium cations (IQs) are neurotoxicants resembling MPP although they are less potent and selective. βCs and IQs have been detected in the human brain but their toxicological significance remains unknown. THβCs/βCs and TIQs are activated to toxic cations by N-methyltransferases (NMT) and/or heme peroxidases and are metabolized by cytochrome P450 enzymes. Remarkably, recent findings suggest, instead, that βCs and TIQs are neuroprotectants and neurorestorative, raising the interest of these molecules., The author is grateful to MINECO (SAF2015-66690-R and SAF2015-68580-C2-2-R) and CSIC (Spain) (project 200470E658) for supporting this work., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Automated techniques in pKa determination: Low, medium and high-throughput screening methods

  • Dardonville, Christophe
Drug discovery programs that generate hundreds of new molecular entities need efficient methodologies for physicochemical profiling. Several high-throughput methods for pK screening have been developed in the last 15 years to determine this key physicochemical parameter. Separation techniques such as HPLC–MS or capillary electrophoresis are particularly well-suited due to their high throughput and capacity to deal with impure or complex samples. In addition, potentiometric and (mostly) UV-metric-based methods (plate-based and automated systems), find their place as very precise methodologies for pK determination despite of somewhat lower throughput. Finally, pK prediction software packages are useful estimator tools but, to date, they cannot replace experimental measurements when accurate pK values are required., This work was funded by the Spanish Ministerio de Economia y Competitividad (SAF2015-66690-R). P.L.A. Popelier is acknowledged for his comments of the manuscript, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SAR of 4-Alkoxybenzoic Acid Inhibitors of the Trypanosome Alternative Oxidase

  • Meco-Navas, A.
  • Ebiloma, Godwin U.
  • Martín-Domínguez, A
  • Martínez-Benayas, I.
  • Cueto-Díaz, Eduardo J.
  • Alhejely, A. S.
  • Balogun, Emmanuel O.
  • Saito, M.
  • Matsui, M.
  • Arai, N.
  • Shiba, Tomoo
  • Harada, Shigeharu
  • de Koning, Harry P.
  • Dardonville, Christophe
The SAR of 4-hydroxybenzaldehyde inhibitors of the trypanosome alternative oxidase (TAO), a critical enzyme for the respiration of bloodstream forms of trypanosomes, was investigated. Replacing the aldehyde group with a methyl ester resulted in a 10-fold increase in TAO inhibition and activity against T. brucei. Remarkably, two analogues containing the 2-hydroxy-6-methyl scaffold (9e and 16e) displayed single digit nanomolar TAO inhibition, which constitute the most potent 4-alkoxybenzoic acid derivatives described to date. 9e was 50-times more potent against TAO and 10-times more active against T. brucei compared to its benzaldehyde analogue 1. The farnesyl derivative 16e was as potent a TAO inhibitor as ascofuranone with IC = 3.1 nM. Similar to ascofuranone derivatives, the 2-hydroxy and 6-methyl groups seemed essential for low nanomolar TAO inhibition of acid derivatives, suggesting analogous binding interactions with the TAO active site., Funding from the Spanish Ministerio de Economia y Competitividad (grant SAF2015-66690-R) is gratefully acknowledged. This research also received funding support from the Japan Society for the promotion of Science (JSPS grant- 17F17420)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Alternative oxidase inhibitors: Mitochondrion-targeting as a strategy for new drugs against pathogenic parasites and fungi

  • Ebiloma, Godwin U.
  • Balogun, Emmanuel O.
  • Cueto-Díaz, Eduardo J.
  • Koning, Harry P. de
  • Dardonville, Christophe
The alternative oxidase (AOX) is a ubiquitous terminal oxidase of plants and many fungi, catalyzing the four-electron reduction of oxygen to water alongside the cytochrome-based electron transfer chain. Unlike the classical electron transfer chain, however, the activity of AOX does not generate adenosine triphosphate but has functions such as thermogenesis and stress response. As it lacks a mammalian counterpart, it has been investigated intensely in pathogenic fungi. However, it is in African trypanosomes, which lack cytochrome-based respiration in their infective stages, that trypanosome alternative oxidase (TAO) plays the central and essential role in their energy metabolism. TAO was validated as a drug target decades ago and among the first inhibitors to be identified was salicylhydroxamic acid (SHAM), which produced the expected trypanocidal effects, especially when potentiated by coadministration with glycerol to inhibit anaerobic energy metabolism as well. However, the efficacy of this combination was too low to be of practical clinical use. The antibiotic ascofuranone (AF) proved a much stronger TAO inhibitor and was able to cure Trypanosoma vivax infections in mice without glycerol and at much lower doses, providing an important proof of concept milestone. Systematic efforts to improve the SHAM and AF scaffolds, aided with the elucidation of the TAO crystal structure, provided detailed structure-activity relationship information and reinvigorated the drug discovery effort. Recently, the coupling of mitochondrion-targeting lipophilic cations to TAO inhibitors has dramatically improved drug targeting and trypanocidal activity while retaining target protein potency. These developments appear to have finally signposted the way to preclinical development of TAO inhibitors., Funding from the Spanish Ministerio de Economia, Industria y Competitividad (grant SAF2015‐66690‐R) and the Japan Society for the Promotion of Science (JSPS grant 17F17420) is gratefully acknowledged., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis and Biological in vitro and in vivo Evaluation of 2-(5-Nitroindazol-1-yl)ethylamines and Related Compounds as Potential Therapeutic Alternatives for Chagas Disease

  • Martín-Escolano, R.
  • Aguilera-Venegas, Benjamín
  • Marín, C.
  • Martín-Montero, Á.
  • Martín-Escolano, J.
  • Medina-Carmona, E.
  • Arán, Vicente J.
  • Sánchez-Moreno, Manuel
Chagas disease, a neglected tropical disease caused by infection with the protozoan parasite Trypanosoma cruzi, is a potentially life-threatening illness that affects 5–8 million people in Latin America, and more than 10 million people worldwide. It is characterized by an acute phase, which is partly resolved by the immune system, but then develops as a chronic disease without an effective treatment. There is an urgent need for new antiprotozoal agents, as the current standard therapeutic options based on benznidazole and nifurtimox are characterized by limited efficacy, toxicity, and frequent failures in treatment. In vitro and in vivo assays were used to identify some new low-cost 5-nitroindazoles as a potential antichagasic therapeutic alternative. Compound 16 (3-benzyloxy-5-nitro-1-vinyl-1H-indazole) showed improved efficiency and lower toxicity than benznidazole in both in vitro and in vivo experiments, and its trypanocidal activity seems to be related to its effect at the mitochondrial level. Therefore, compound 16 is a promising candidate for the development of a new anti-Chagas agent, and further preclinical evaluation should be considered., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINEICO), project reference SAF2015-66690-R and Consolider Ingenio CSD2010-00065, by FONDECYT (Chile), project reference 11150559, and by the Junta de Andaluc&a, project reference P11-CTS-07187. R.M.-E. is grateful for a FPU Grant (FPU14/01537) from the Ministry of Education of Spain. E.M.-C. acknowledges a predoctoral fellowship from Junta de Andalucia, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In vitro assessment of 3-alkoxy-5-nitroindazole-derived ethylamines and related compounds as potential antileishmanial drugs

  • Martín-Montes, Á.
  • Aguilera-Venegas, Benjamín
  • Morales-Martín, Rosa Mª
  • Martín-Escolano, R.
  • Zamora-Ledesma, S.
  • Marín, C.
  • Arán, Vicente J.
  • Sánchez-Moreno, Manuel
Leishmaniasis is a widespread neglected tropical disease complex that is responsible of one million new cases per year. Current treatments are outdated and pose many problems that new drugs need to overcome. With the goal of developing new, safe, and affordable drugs, we have studied the in vitro activity of 12 different 5-nitroindazole derivatives that showed previous activity against different strains of Trypanosoma cruzi in a previous work. T. cruzi belongs to the same family as Leishmania spp., and treatments for the disease it produces also needs renewal. Among the derivatives tested, compounds 1, 2, 9, 10, 11, and 12 showed low J774.2 macrophage toxicity, while their effect against both intracellular and extracellular forms of the studied parasites was higher than the ones found for the reference drug Meglumine Antimoniate (Glucantime®). In addition, their Fe-SOD inhibitory effect, the infection rates, metabolite alteration, and mitochondrial membrane potential of the parasites treated with the selected drugs were studied in order to gain insights into the action mechanism, and the results of these tests were more promising than those found with glucantime, as the leishmanicidal effect of these new drug candidates was higher. The promising results are encouraging to test these derivatives in more complex studies, such as in vivo studies and other experiments that could find out the exact mechanism of action., Authors appreciate the financial support from the Spanish Ministry of Science, Innovation and Universities (projects SAF2015-66690-R and RTI2018-093940-B-I00) and Spanish Ministry of Education and Science (project CSD 2010-00065). R.M.E. is grateful for a FPU grant [FPU14/01537] from the Ministry of Education of Spain and B.A.V. is grateful for an initiation into research grant from FONDECYT 11150559, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antimalarial quinoline drugs inhibit β-hematin and increase free hemin catalyzing peroxidative reactions and inhibition of cysteine proteases

  • Herraiz Tomico, Tomás
  • Guillén Fuerte, Hugo
  • González Peña, Diana
  • Arán, Vicente J.
Malaria caused by Plasmodium affects millions people worldwide. Plasmodium consumes hemoglobin during its intraerythrocytic stage leaving toxic heme. Parasite detoxifies free heme through formation of hemozoin (β-hematin) pigment. Proteolysis of hemoglobin and formation of hemozoin are two main targets for antimalarial drugs. Quinoline antimarial drugs and analogs (β-carbolines or nitroindazoles) were studied as inhibitors of β-hematin formation. The most potent inhibitors were quinacrine, chloroquine, and amodiaquine followed by quinidine, mefloquine and quinine whereas 8-hydroxyquinoline and β-carbolines had no effect. Compounds that inhibited β-hematin increased free hemin that promoted peroxidative reactions as determined with TMB and ABTS substrates. Hemin-catalyzed peroxidative reactions were potentiated in presence of proteins (i.e. globin or BSA) while antioxidants and peroxidase inhibitors decreased peroxidation. Free hemin increased by chloroquine action promoted oxidative reactions resulting in inhibition of proteolysis by three cysteine proteases: papain, ficin and cathepsin B. Glutathione reversed inhibition of proteolysis. These results show that active quinolines inhibit hemozoin and increase free hemin which in presence of HO that abounds in parasite digestive vacuole catalyzes peroxidative reactions and inhibition of cysteine proteases. This work suggests a link between the action of quinoline drugs with biochemical processes of peroxidation and inhibition of proteolysis., The authors thank Spanish Government-FEDER through projects RTI2018-093940-B-I00, RTI2018-095544-B-I00 and SAF-2015-66690-R. EY and FV are recipients of “Garantía Juvenil” fellowships from Comunidad de Madrid (Fondo Social Europeo-Iniciativa de Empleo Juvenil).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery and pharmacological studies of 4-hydroxyphenyl-derived phosphonium salts active in a mouse model of visceral Leishmaniasis

  • Manzano, José Ignacio
  • Cueto-Díaz, Eduardo J.
  • Olías-Molero, Ana Isabel
  • Perea Martínez, Ana
  • Herraiz Tomico, Tomás
  • Torrado, Juan J.
  • Alunda, José María
  • Gamarro, Francisco
  • Dardonville, Christophe
We report the discovery of new 4-hydroxyphenyl phosphonium salt derivatives active in the submicromolar range (EC from 0.04 to 0.28 μM, SI > 10) against the protozoan parasite Leishmania donovani. The pharmacokinetics and in vivo oral efficacy of compound 1 [(16-(2,4-dihydroxyphenyl)-16-oxohexadecyl)triphenylphosphonium bromide] in a mouse model of visceral leishmaniasis were established. Compound 1 reduced the parasite load in spleen (98.9%) and liver (95.3%) of infected mice after an oral dosage of four daily doses of 1.5 mg/kg. Mode of action studies showed that compound 1 diffuses across the plasma membrane, as designed, and targets the mitochondrion of Leishmania parasites. Disruption of the energetic metabolism, with a decrease of intracellular ATP levels as well as mitochondrial depolarization together with a significant reactive oxygen species production, contributes to the leishmanicidal effect of 1. Importantly, this compound was equally effective against antimonials and miltefosine-resistant clinical isolates of Leishmania infantum, indicating its potential as antileishmanial lead., Funding from the Spanish Ministerio de Economia y Competitividad (grant SAF2015-66690-R) and the Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU/AEI/FEDER, UE; grants RTI2018-093940-B-I00 to C.D. and RTI2018-097210-B-I00 to F.G.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Activity profile of two 5-nitroindazole derivatives over the moderately drug-resistant Trypanosoma cruzi Y strain (DTU TcII): in vitro and in vivo studies

  • Fonseca-Berzal, Cristina
  • da Silva, C. F.
  • Batista, D. d. G. J.
  • de Oliveira, G. M.
  • Cumella, José
  • Batista, M. M.
  • Peres, R. B.
  • Silva da Gama Nefertiti, A.
  • Escario, José Antonio
  • Gómez-Barrio, Alicia
  • Arán, Vicente J.
  • Soeiro, M. d. N. C.
In previous studies, we have identified several families of 5-nitroindazole derivatives as promising antichagasic prototypes. Among them, 1-(2-aminoethyl)-2-benzyl-5-nitro-1,2-dihydro-3H-indazol-3-one, (hydrochloride) and 1-(2-acetoxyethyl)-2-benzyl-5-nitro-1,2-dihydro-3H-indazol-3-one (compounds 16 and 24, respectively) have recently shown outstanding activity in vitro over the drug-sensitive Trypanosoma cruzi CL strain (DTU TcVI). Here, we explored the activity of these derivatives against the moderately drug-resistant Y strain (DTU TcII), in vitro and in vivo. The outcomes confirmed their activity over replicative forms, showing IC50 values of 0.49 (16) and 5.75 μm (24) towards epimastigotes, 0.41 (16) and 1.17 μm (24) against intracellular amastigotes. These results, supported by the lack of toxicity on cardiac cells, led to better selectivities than benznidazole (BZ). Otherwise, they were not as active as BZ in vitro against the non-replicative form of the parasite, i.e. bloodstream trypomastigotes. In vivo, acute toxicity assays revealed the absence of toxic events when administered to mice. Moreover, different therapeutic schemes pointed to their capability for decreasing the parasitaemia of T. cruzi Y acute infected mice, reaching up to 60% of reduction at the peak day as monotherapy (16), 79.24 and 91.11% when 16 and 24 were co-administered with BZ. These combined therapies had also a positive impact over the mortality, yielding survivals of 83.33 and 66.67%, respectively, while untreated animals reached a cumulative mortality of 100%. These findings confirm the 5-nitroindazole scaffold as a putative prototype for developing novel drugs potentially applicable to the treatment of Chagas disease and introduce their suitability to act in combination with the reference drug., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness(MINEICO,ref.SAF2015-66690-R), the National Council for Scientific and Technological Development of Brazil (CNPq, ref. 301372/2015-2) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ,ref. E02/2017). The 911120 UCM-CEI Moncloa Research Group‘Epidemiología, Diagnóstico y Terapia Antiparasitaria’and the Spanish Ministry of Science, Innovation and Universities (MICIU, ref.RTI-2018-093940-B-I00) are also acknowledged. M.N.C.S. is a research fellowof CNPq and CNE researcher.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Synthesis, biological, and photophysical studies of molecular rotorbased fluorescent inhibitors of the trypanosome alternative oxidase

  • Cueto-Díaz, Eduardo J.
  • Ebiloma, Godwin U.
  • Alfayez, Ibrahim A.
  • Ungogo, Marzuq A.
  • Lemgruber, Leandro
  • González-García, Carmen
  • Giron, Maria D.
  • Salto, Rafael
  • Fueyo-González, Francisco
  • Shiba, Tomoo
  • González-Vera, Juan A.
  • Ruedas Rama, Maria José
  • de Koning, Harry P.
  • Dardonville, Christophe
We have recently reported on the development and trypanocidal activity of a class of inhibitors of Trypanosome Alternative Oxidase (TAO) that are targeted to the mitochondrial matrix by coupling to lipophilic cations via C14 linkers to enable optimal interaction with the enzyme’s active site. This strategy resulted in a much-enhanced anti-parasite effect, which we ascribed to the greater accumulation of the compound at the location of the target protein, i.e. the mitochondrion, but to date this localization has not been formally established. We therefore synthesized a series of fluorescent analogues to visualize accumulation and distribution within the cell. The fluorophore chosen, julolidine, has the remarkable extra feature of being able to function as a viscosity sensor and might thus additionally act as a probe of the cellular glycerol that is expected to be produced when TAO is inhibited. Two series of fluorescent inhibitor conjugates incorporating a cationic julolidine-based viscosity sensor were synthesized and their photophysical and biological properties were studied. These probes display a red emission, with a high signal-to-noise ratio (SNR), using both single- and two-photon excitation. Upon incubation with T. brucei and mammalian cells, the fluorescent inhibitors 1a and 2a were taken up selectively in the mitochondria as shown by live-cell imaging. Efficient partition of 1a in functional isolated (rat liver) mitochondria was estimated to 66 ± 20% of the total. The compounds inhibited recombinant TAO enzyme in the submicromolar (1a, 2c, 2d) to low nanomolar range (2a) and were effective against WT and multidrug-resistant trypanosome strains (B48, AQP1-3 KO) in the submicromolar range. Good selectivity (SI > 29) over mammalian HEK cells was observed. However, no viscosity-related shift could be detected, presumably because the glycerol was produced cytosolically, and released through aquaglyceroporins, whereas the probe was located, virtually exclusively, in the trypanosome’s mitochondrion., This work was supported by the Spanish Ministerio de Economia y Competitividad (grant SAF2015-66690-R), the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU/AEI/FEDER, UE; grants RTI2018-093940-B-I00 to CD, and CTQ2017-85658-R toAO) and the Japan Society for the promotion of Science (JSPS grant- 17F17420 to GUE). MAU is funded through a studentship from the Petroleum Technology Development Fund (PTDF), Abuja, Nigeria. IAA was funded through a Ph.D. studentship from the Ministry of Health of Saudi Arabia.We thank Dr. José Cumella for the synthesis of the 1,14-dibromotetradecane precursor and to Prof. Ibon Alkorta for his help with DFT calculations. We also thank Professor Fred Opperdoes and Dr Alena Zíkova for their insightful discussions on T. brucei energy metabolism., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

5-Nitroindazole-based compounds: further studies for activity optimization as anti-Trypanosoma cruzi agents

  • Fonseca-Berzal, Cristina
  • Ibáñez-Escribano, Alexandra
  • Castro, Sonia de
  • Escario, José Antonio
  • Gómez-Barrio, Alicia
  • Arán, Vicente J.
In this study, a new series of eleven 5-nitroindazole derivatives (10−20) and a related 6-nitroquinazoline (21) was synthesized and tested in vitro against different forms of the kinetoplastid parasite Trypanosoma cruzi, etiological agent of Chagas disease. Among these compounds, derivatives 11−14 and 17 showed trypanocidal profiles on epimastigotes (IC50 = 1.00−8.75 µM) considerably better than that of the reference drug benznidazole, BZ (IC50 = 25.22 µM). Furthermore, the lack of cytotoxicity observed for compounds 11, 12, 14, 17 and 18 over L929 fibroblasts, led to a notable selectivity (SI) on the extracellular replicative form of the parasite: SIEPI > 12.41 to > 256 µM. Since these five derivatives overpassed the cut-off value established by BZ (SIEPI ≥ 10), they were moved to a more specific assay against the intracellular and replicative form of T. cruzi, i.e, amastigotes. These molecules were not as active as BZ (IC50 = 0.57 µM) against this parasite form; however, all of them showed remarkable IC50 values lower than 7 µM. Special mention deserve compounds 12 and 17, whose SIAMA were > 246.15 and > 188.23, respectively. The results compiled in the present work, point to a positive impact over the trypanocidal activity of the electron withdrawing substituents introduced at position 2 of the N-2 benzyl moiety of these compounds, especially fluorine, i.e., derivatives 12 and 17. These outcomes, supported by the in silico prediction of good oral bioavailability and suitable risk profile, reinforce the 5-nitroindazole scaffold as an adequate template for preparing potential antichagasic agents., This work was partially supported by the Spanish Ministry of Econ- omy, Industry and Competitiveness (MINEICO, ref. SAF2015-66690-R) and the 911120 UCM Research Group “Epidemiología, Diagnóstico y Terapia Antiparasitaria”. The Spanish Ministry of Science, Innovation and Universities (MICIU, ref. RTI2018-093940-B-I00) is also acknowledged, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nitroindazolinone derivatives: assessing the impact of the nitro group location on the activity against Trypanosoma cruzi

  • Fonseca-Berzal, Cristina
  • França Da Silva, Cristiane
  • Bernardino Da Silva, Patrícia
  • Meuser Batista, Marcos
  • Gómez-Barrio, Alicia
  • Vela, Nerea
  • Arán, Vicente J.
  • Correia Soeiro, Maria De Nazaré
Inthelastdecades,different5-nitroindazole-basedcompoundshavebeensynthesizedandproposed as potential agents for treating the infection caused by Trypanosoma cruzi, i.e. Chagas disease. In previous works, the 1,2-disubstituted 5-nitroindazolinone system has been identified as a promising scaffold to design compounds, among which derivatives with a benzyl moietyat N-2standout.Now,wehavesynthesized4-,6-and7-nitroindazolin-3-ones(19–24), analogues of the previously studied 2-benzyl-1-methyl-5-nitroindazolinone (1) and 2-benzyl5-nitro-1-propylindazolinone (2), to explore the impact of the nitro group position on their trypanocidal activity. These 8 nitro derivatives were in silico predicted to have good oral bioavailability and no toxicity risks. In vitro assays over bloodstream trypomastigotes (Y strain, DTUTcII) showed animprovement in the lytic profile of 2-benzyl-1-propyl derivatives, when the NO2 group is moved to position 6 of the indazole ring: EC50 = 34.55 µM (23) versus EC50 > 50 µM (2, 22 and 24). Regarding the assays on amastigotes (Tulahuen strain, DTU TcVI), 4-, 6- and 7-nitroindazoles did not display better activity (EC50 from 3.82 to > 20 µM) than 5-nitroindazoles, with EC50 = 2.34 (1) and 3.03 µM (2). The lack of cytotoxicity over cardiac (CC50 > 200 µM) and L929 cells (CC50 > 170 µM) supports selective action, particularly of 5-nitroindazolinones towards intracellular forms: SI > 85.47 (1) and 56.53 (2). Altogether, data indicate that the anti-T. cruzi activity of 4-, 6- and 7-nitroindazolinones is not better than that of 1 and 2, not presenting significant advantages over these two 5-nitroindazolinones., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINEICO, SAF2015-66690-R), the National Council for Scientific and Technological Development of Brazil (CNPq, 301372/2015-2) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ, E02/2017). The Spanish Ministry of Science and Innovation (MICINN, PID2022-136438OB-I00) and the 911120 UCM Research Group ‘Epidemiología, Diagnóstico y Terapia Antiparasitaria’ are also acknowledged. M..N.C.S. is a research fellow of CNPq and CNE researcher., Peer reviewed